Compare SUN & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SUN | EXEL |
|---|---|---|
| Founded | 1886 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 11.1B |
| IPO Year | N/A | 2000 |
| Metric | SUN | EXEL |
|---|---|---|
| Price | $52.64 | $46.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 23 |
| Target Price | ★ $63.75 | $45.18 |
| AVG Volume (30 Days) | 352.3K | ★ 2.6M |
| Earning Date | 02-10-2026 | 02-10-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | N/A | ★ 53.55 |
| EPS | ★ 2.93 | 2.38 |
| Revenue | ★ $21,870,000,000.00 | $2,288,218,000.00 |
| Revenue This Year | $2.83 | $9.79 |
| Revenue Next Year | $10.99 | $12.01 |
| P/E Ratio | ★ $18.07 | $19.46 |
| Revenue Growth | N/A | ★ 9.93 |
| 52 Week Low | $47.98 | $31.90 |
| 52 Week High | $59.88 | $49.62 |
| Indicator | SUN | EXEL |
|---|---|---|
| Relative Strength Index (RSI) | 45.93 | 67.29 |
| Support Level | $52.01 | $40.83 |
| Resistance Level | $52.98 | $47.24 |
| Average True Range (ATR) | 0.90 | 1.27 |
| MACD | -0.17 | 0.40 |
| Stochastic Oscillator | 28.17 | 84.57 |
Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.